Publication | Open Access
Efficacy and safety of Abraxane in treatment of progressive and recurrent non‐small cell lung cancer patients: A retrospective clinical study
33
Citations
22
References
2012
Year
Recurrent and progressive NSCLC patients pretreated with platinum-based chemotherapy might benefit from Abraxane with tolerable adverse events.
| Year | Citations | |
|---|---|---|
Page 1
Page 1